Belfast-based techbio company AMPLY Discovery has raised over £1.4 ($1.7) million in grant funding to develop new drugs using its AI-driven drug discovery platform. The company, which is a spin-out from the Queen’s University Belfast, was established in 2021 to commercialise a drug discovery platform developed by researchers in the School of Biological Science at […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!